Humonix Bio Announces Appointment of Thurein Htoo as Chairman of the Board of Directors and Welcomes Christie Markowitz as New Independent Board Director
Humonix Biosciences, Inc., a leading specialty pharmaceutical research company, is pleased to announce the appointment of Thurein Htoo as the new Chairman of the Board...
uBriGene Biosciences Congratulates Strategic Partner InnoVec Biotherapeutics on FDA Clearance of IND for IVB103, an AAV-Based Gene Therapy
uBriGene Biosciences (uBriGene), a global CDMO leader, is excited to announce that its strategic partner, InnoVec Biotherapeutics, has received FDA clearance for its Investigational New...
Elixirgen Scientific Launches Advanced hiPSC-Derived Disease Panel for Alzheimer’s Disease
Maryland-based biotechnology leader, Elixirgen Scientific, Inc., launches Alzheimer’s Disease Panel, strengthening their commitment to quality and innovation in disease research and drug discovery. Elixirgen Scientific,...
Data4Cure to Present at the BIO International Convention 2024
Data4Cure, a leading biomedical data-to-knowledge company, today announced its upcoming presentation at the BIO International Convention 2024 taking place June 3-6, 2024, in San Diego,...
Humonix Biosciences Appoints Karen Torrejon, PhD, as New Chief Executive Officer
Dr. Torrejon, the original founder of Humonix, replaces Kimberly Southern Humonix Biosciences, Inc. (“Humonix”), a specialty pharmaceutical research company focused on 3D human tissue models...
Pace® Life Sciences Adds Liquid Capsule Filling Technology
Pace® Life Sciences continues to make investments to broaden their comprehensive suite of oral solid dose development offerings. Pace® Life Sciences, a full-service contract development and...
Incite Health, Inc. Introduces Pharmacogenomics Services to Improve the Safety, Efficacy, and Efficiency of Clinical Trials
New innovative clinical services to help pharmaceutical and biotech companies improve patient recruitment, reduce the risk of adverse reactions, and refine the drug development process....
AmplifyBio Selects Apprentice.io’s Tempo Manufacturing Execution System to Supercharge Manufacturing Capabilities as They Expand Capacity
AmplifyBio, a leading service provider in discovery, safety, and manufacturing services for the development of advanced therapies, has chosen Apprentice.io’s cutting-edge Tempo Manufacturing Execution System...
Pace Life Sciences Presents Workshop Designed to Navigate the Complex Regulatory Terrain of Early-Phase Drug Development
Complimentary Workshop to Provide Expert Insight and Strategies for Regulatory Affairs Specialists, Pharmaceutical Enthusiasts and Drug Developers Pace® Life Sciences, a leading full-service pharmaceutical contract...
Humonix Biosciences Launches New 3D Human Tissue Model
Specialty pharmaceutical research company’s new retinal vascular dysfunction model can have a major impact on research and development of new drugs for retinal vascular diseases....